This article first appeared on GuruFocus. Gland Pharma Ltd (NSE:GLAND) is set to release its Q2 2026 earnings on Nov 3, 2025. The consensus estimate for Q2 2026 revenue is $15.56 billion, and the ...

MUMBAI (Reuters) - Private equity firm KKR & Co LP (NYS:KKR - News) will pay about $150 million for close to 30 percent of India's Gland Pharma Ltd, two sources with direct knowledge of the matter ...

Jan 28 (Reuters) - India's Gland Pharma reported a nearly 28% jump in third-quarter profit on Wednesday, boosted by strong sales in the key European and U.S. markets. The Hyderabad-based company ...

Hyderabad: Gland Pharma Limited, a generic injectable and ophthalmic-focused pharmaceutical company, has received approval ...

MUMBAI, India--(BUSINESS WIRE)--Gland Pharma Limited (“Company” or “Gland Pharma”), a leading Indian pure-play generic injectable pharmaceutical products company, today announced an agreement under ...

FILE PHOTO: A Palestinian health worker displays a vial of Russia's Sputnik V vaccine as he prepares to vaccinate Matthias Schmale, UNRWA's Gaza director, against the coronavirus disease (COVID-19), ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Gland Pharma, Somerset Therapeutics, Odin Pharmaceuticals and two Qilu companies were hit with a patent infringement lawsuit on Nov. 13 in Delaware District Court over their proposed generic versions ...

Based on the one-year price targets offered by 14 analysts, the average target price for Gland Pharma Ltd (NSE:GLAND) is $2005.64 with a high estimate of $2360 and a low estimate of $1555. The average ...